Related references
Note: Only part of the references are listed.Long Noncoding RNA KCNQ1OT1 Confers Gliomas Resistance to Temozolomide and Enhances Cell Growth by Retrieving PIM1 From miR-761
Wei Wang et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2022)
Emerging Role of Long Non-Coding RNAs in the Pathobiology of Glioblastoma
Omidvar Rezaei et al.
FRONTIERS IN ONCOLOGY (2021)
NCK1-AS1 Increases Drug Resistance of Glioma Cells to Temozolomide by Modulating miR-137/TRIM24
Mingsheng Chen et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2020)
LINC00174 down-regulation decreases chemoresistance to temozolomide in human glioma cells by regulating miR-138-5p/SOX9 axis
Bin Li et al.
HUMAN CELL (2020)
Interfering with long non-coding RNA MIR22HG processing inhibits glioblastoma progression through suppression of Wnt/β-catenin signalling
Mingzhi Han et al.
BRAIN (2020)
Microarray expression profiles and bioinformatics analysis of mRNAs, lncRNAs, and circRNAs in the secondary temozolomide-resistant glioblastoma
Chengbin Zhao et al.
INVESTIGATIONAL NEW DRUGS (2020)
DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma
Chenfei Lu et al.
MOLECULAR CANCER (2020)
Long intergenic noncoding RNA 00021 promotes glioblastoma temozolomide resistance by epigenetically silencing p21 through Notch pathway
Shitao Zhang et al.
IUBMB LIFE (2020)
HOTAIR/miR-125 axis-mediated Hexokinase 2 expression promotes chemoresistance in human glioblastoma
Jinnan Zhang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
lncRNA CCAT2 Enhanced Resistance of Glioma Cells Against Chemodrugs by Disturbing the Normal Function of miR-424
Jun Ding et al.
ONCOTARGETS AND THERAPY (2020)
LncRNA SOX2OT promotes temozolomide resistance by elevating SOX2 expression via ALKBH5-mediated epigenetic regulation in glioblastoma
Boyang Liu et al.
CELL DEATH & DISEASE (2020)
Identification of an Immune-Related Nine-lncRNA Signature Predictive of Overall Survival in Colon Cancer
Yilin Lin et al.
FRONTIERS IN GENETICS (2020)
Expression analysis of vimentin and the related lncRNA network in breast cancer
Mehdi Mohebi et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2020)
Long Non-coding RNA EPIC1 Promotes Cell Proliferation and Motility and Drug Resistance in Glioma
Jianjiao Wang et al.
MOLECULAR THERAPY-ONCOLYTICS (2020)
NCK1-AS1 enhances glioma cell proliferation, radioresistance and chemoresistance via miR-22-3p/IGF1R ceRNA pathway
Bo Wang et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
NR5A2 Promotes Cell Growth and Resistance to Temozolomide Through Regulating Notch Signal Pathway in Glioma
Quanxi Yang et al.
ONCOTARGETS AND THERAPY (2020)
OKN-007 Increases temozolomide (TMZ) Sensitivity and Suppresses TMZ-Resistant Glioblastoma (GBM) Tumor Growth
Rheal A. Towner et al.
TRANSLATIONAL ONCOLOGY (2019)
The lncRNA TP73-AS1 is linked to aggressiveness in glioblastoma and promotes temozolomide resistance in glioblastoma cancer stem cells
Gal Mazor et al.
CELL DEATH & DISEASE (2019)
Knockdown of lncRNA HOXD-AS1 suppresses proliferation, migration and invasion and enhances cisplatin sensitivity of glioma cells by sponging miR-204
Hui Zhou et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Temozolomide Treatment Induces lncRNA MALAT1 in an NF-κB and p53 Codependent Manner in Glioblastoma
David J. Voce et al.
CANCER RESEARCH (2019)
Exosomal transfer of long non-coding RNA SBF2-AS1 enhances chemoresistance to temozolomide in glioblastoma
Zhuoran Zhang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
ZFAS1 knockdown inhibits viability and enhances cisplatin cytotoxicity by up-regulating miR-432-5p in glioma cells
Gongli Yang et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2019)
LINC01198 promotes proliferation and temozolomide resistance in a NEDD4-1-dependent manner, repressing PTEN expression in glioma
Wei-Lin Chen et al.
AGING-US (2019)
Modulating lncRNA SNHG15/CDK6/miR-627 circuit by palbociclib, overcomes temozolomide resistance and reduces M2-polarization of glioma associated microglia in glioblastoma multiforme
Zhenzhe Li et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Autophagy: A novel mechanism of chemoresistance in cancers
Xinyu Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Novel Function of lncRNA ADAMTS9-AS2 in Promoting Temozolomide Resistance in Glioblastoma via Upregulating the FUS/MDM2 Ubiquitination Axis
Yuanliang Yan et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)
Long noncoding RNA growth arrest-specific 5 facilitates glioma cell sensitivity to cisplatin by suppressing excessive autophagy in an mTOR-dependent manner
Jun-Feng Huo et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Targeted nanocomplex carrying siRNA against MALAT1 sensitizes glioblastoma to temozolomide
Sang-Soo Kim et al.
NUCLEIC ACIDS RESEARCH (2018)
Long non-coding RNA UCA1/miR-182/PFKFB2 axis modulates glioblastoma-associated stromal cells-mediated glycolysis and invasion of glioma cells
Zongze He et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Upregulation of CASC2 sensitized glioma to temozolomide cytotoxicity through autophagy inhibition by sponging miR-193a-5p and regulating mTOR expression
Chunming Jiang et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Long non-coding RNA TUSC7 inhibits temozolomide resistance by targeting miR-10a in glioblastoma
Chao Shang et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2018)
Long noncoding RNA DANCR mediates cisplatin resistance in glioma cells via activating AXL/PI3K/Akt/NF-κB signaling pathway
Yangang Ma et al.
NEUROCHEMISTRY INTERNATIONAL (2018)
The silencing of LncRNA-H19 decreases chemoresistance of human glioma cells to temozolomide by suppressing epithelial-mesenchymal transition via the Wnt/beta-Catenin pathway
Linwei Jia et al.
ONCOTARGETS AND THERAPY (2018)
The lncRNA H19 positively affects the tumorigenic properties of glioblastoma cells and contributes to NKD1 repression through the recruitment of EZH2 on its promoter
Barbara Fazi et al.
Oncotarget (2018)
Long noncoding RNA MALAT1 knockdown reverses chemoresistance to temozolomide via promoting microRNA-101 in glioblastoma
Tao Cai et al.
CANCER MEDICINE (2018)
H19 induced by oxidative stress confers temozolomide resistance in human glioma cells via activating NF-kappa B signaling
Shibo Duan et al.
ONCOTARGETS AND THERAPY (2018)
Long noncoding RNA AC003092.1 promotes temozolomide chemosensitivity through miR-195/TFPI-2 signaling modulation in glioblastoma
Ningbo Xu et al.
CELL DEATH & DISEASE (2018)
Genomic profiling of long non-coding RNA and mRNA expression associated with acquired temozolomide resistance in glioblastoma cells
Huijun Zeng et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
LncRNA CASC2 Interacts With miR-181a to Modulate Glioma Growth and Resistance to TMZ Through PTEN Pathway
Yiwei Liao et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2017)
Wnt/beta-catenin pathway: modulating anticancer immune response
Sachin Gopalkrishna Pai et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
Long non-coding RNA MEG3 contributes to cisplatin-induced apoptosis via inhibition of autophagy in human glioma cells
Binbin Ma et al.
MOLECULAR MEDICINE REPORTS (2017)
MALAT1 is a prognostic factor in glioblastoma multiforme and induces chemoresistance to temozolomide through suppressing miR-203 and promoting thymidylate synthase expression
Wei Chen et al.
ONCOTARGET (2017)
Long Non-Coding RNA MALAT1 Decreases the Sensitivity of Resistant Glioblastoma Cell Lines to Temozolomide
Hongwei Li et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
LncRNA-XIST interacts with miR-29c to modulate the chemoresistance of glioma cell to TMZ through DNA mismatch repair pathway
Peng Du et al.
BIOSCIENCE REPORTS (2017)
Long non-coding RNA AC023115.3 suppresses chemoresistance of glioblastoma by reducing autophagy
Binbin Ma et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2017)
WIF1 re-expression in glioblastoma inhibits migration through attenuation of non-canonical WNT signaling by downregulating the lncRNA MALAT1
I. Vassallo et al.
ONCOGENE (2016)
Knockdown of long noncoding RNA H19 sensitizes human glioma cells to temozolomide therapy
Pengfei Jiang et al.
ONCOTARGETS AND THERAPY (2016)
Long noncoding RNA RP11-838N2.4 enhances the cytotoxic effects of temozolomide by inhibiting the functions of miR-10a in glioblastoma cell lines
Yanting Liu et al.
ONCOTARGET (2016)
Roles, Functions, and Mechanisms of Long Non-coding RNAs in Cancer
Yiwen Fang et al.
GENOMICS PROTEOMICS & BIOINFORMATICS (2016)
Temozolomide resistance in glioblastoma multiforme
Sang Y. Lee
GENES & DISEASES (2016)
To Be or Not to Be? How Selective Autophagy and Cell Death Govern Cell Fate
Douglas R. Green et al.
CELL (2014)
Pervasive Transcription of the Human Genome Produces Thousands of Previously Unidentified Long Intergenic Noncoding RNAs
Matthew J. Hangauer et al.
PLOS GENETICS (2013)
Landscape of transcription in human cells
Sarah Djebali et al.
NATURE (2012)
An integrated encyclopedia of DNA elements in the human genome
Ian Dunham et al.
NATURE (2012)
Autophagy as a target for anticancer therapy
Filip Janku et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Brain Tumor Susceptibility: the Role of Genetic Factors and Uses of Mouse Models to Unravel Risk
Karlyne M. Reilly
BRAIN PATHOLOGY (2009)
Mechanisms of chemoresistance to alkylating agents in malignant glioma
Jann N. Sarkaria et al.
CLINICAL CANCER RESEARCH (2008)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Exosome-Mediated Transfer of Long Noncoding RNA HOTAIR Regulates Temozolomide Resistance by miR-519a-3p/RRM1 Axis in Glioblastoma
Zhihai Yuan et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
Share Paper
